The Ministry of Health and Prevention has called on all citizens to participate in the Emirates Genome Program, which aims to provide the best levels of health care to understand the nature of genetic diseases prevalent in the UAE society by using genomics and applying personalized medicine for Emirati patients and families in order to provide accurate diagnosis and appropriate treatment. For patients, enhancing the prevention of genetic and chronic diseases in future generations, and reinventing the country’s health policies in the future, relying on national competencies and in cooperation with the most prestigious medical research centers to enhance the country’s position as a global center for innovation in the health sector and raise the country’s position in the global competitiveness index.
The Emirati Genome Open Program, with the participation of all citizens, aims to provide better insights into the genetic diversity of the country’s citizens, as participants in this program contribute to a scientific discovery process that has many potential benefits in the future, including the adoption of strategies dedicated to health services throughout the country and support for the transition from the model. The traditional interactive of healthcare services to managing them more proactively and preemptively.
The program was launched in cooperation with the Department of Health – Abu Dhabi, and it is one of the initiatives of the “Omex” Center of Excellence that was recently launched by the “G42” Healthcare Company. It is considered the largest biological science facility “OMEX” in the region and the most technologically advanced.
The experimental phase of the Emirati genome program had successfully ended with G42 healthcare experts establishing the first new reference genome for Emiratis based on DNA samples collected from 1000 citizens. The samples were analyzed using third-generation genetic sequencing platforms. A sophisticated next generation powered by artificial intelligence.
The reference genome will be used as a qualitative standard for individual genomes to be measured to diagnose hereditary health conditions and supplement treatment plans with important data in order to provide customized health care to UAE citizens.
His Excellency Abdul Rahman bin Muhammad Al Owais, Minister of Health and Community Protection, called on citizens to participate in the program .. and said: One of our main priorities is to develop a preventive health care system in line with the UAE’s vision for the next 50 years, and the UAE Genome Program is one of the most comprehensive and ambitious genome programs in The world, which is our main initiative to provide a preventive health system dedicated to Emirati citizens … We look forward to the participation of all citizens of the country in the program and to help us achieve our goal of providing innovative and world-class health services and building a healthier future.
His Excellency indicated that the UAE Genome Project is one of the pioneering projects to explore the future of the health care sector and enter a new era of genetic medicine based on the use of genetic information as part of clinical care with the aim of strengthening the prevention of genetic and chronic diseases such as obesity, diabetes, blood pressure, cancer and asthma, and access to personalized treatment for each Patient according to genetic factors, through the use of genetic science and innovative modern techniques on profiling and genetic sequencing to identify the genetic fingerprint.
For his part, Ashish Kochi, CEO of G42 Healthcare, said that the UAE Genome Program aims to achieve a new exceptional achievement in the UAE healthcare sector, as we urge Emirati citizens of all ages to participate in the program and contribute to building a healthier future for future generations. Expressing his happiness at the wide response the program received with its launch in Abu Dhabi, expressing the aspiration for the participation of all citizens from across the Emirates who will play a pivotal role in shaping the future of health care in the country.
The success of the Emirates Genome Program depends greatly on the voluntary participation of Emirati citizens across the country, as the increase in the number of volunteers will contribute to enhancing the comprehensiveness of genome results data and thus establishing a rich database that scientists and medical experts benefit from to create the Emirati reference genome.
Emirati volunteers can visit a sample collection center in the exhibition hall of the Abu Dhabi National Exhibition Center and the “Biogenics Laboratory” in “Masdar” city in Abu Dhabi, where a team of health care experts will be waiting for them to assist them during the process.
Other additional sample collection centers will be opened throughout the country in the coming weeks and months, where volunteers will be required to register their explicit consent before joining the program.
Details of the UAE Genome Program, including full information on how to participate, can also be found on www.emiratigenomeprogram.ae or by calling 800 UAE GENOME.